CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $201,787
- in 1 filing
Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-07 | KOCH KEVIN President and CEO | Option exercise 10b5-1 | +100 | $0.18 | $18 | 14,578 |
| 2025-03-07 | KOCH KEVIN President and CEO | Sale 10b5-1 | −100 | $30.00 | $3K | 14,478 |
| 2025-03-07 | KOCH KEVIN President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −100 | 41,545 | ||
| 2025-02-06 | Russell Alan J Chief Scientific Officer | Option exercise 10b5-1 | +1,200 | $0.18 | $216 | 16,063 |
| 2025-02-06 | Russell Alan J Chief Scientific Officer | Sale 10b5-1 | −1,200 | $30.13 | $36K | 14,863 |
| 2025-02-06 | Russell Alan J Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,200 | 1,347,565 | ||
| 2025-02-06 | KOCH KEVIN President and CEO | Option exercise 10b5-1 | +900 | $13.11 | $12K | 15,378 |
| 2025-02-06 | KOCH KEVIN President and CEO | Sale 10b5-1 | −900 | $31.13 | $28K | 14,478 |
| 2025-02-06 | KOCH KEVIN President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −900 | 41,645 | ||
| 2025-02-05 | Russell Alan J Chief Scientific Officer | Option exercise 10b5-1 | +8,015 | $0.18 | $1K | 22,878 |
| 2025-02-05 | Russell Alan J Chief Scientific Officer | Sale 10b5-1 | −8,015 | $30.02 | $241K | 14,863 |
| 2025-02-05 | Russell Alan J Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,015 | 1,348,765 | ||
| 2025-02-05 | KOCH KEVIN President and CEO | Option exercise 10b5-1 | +8,636 | $0.18 | $2K | 23,114 |
| 2025-02-05 | KOCH KEVIN President and CEO | Sale 10b5-1 | −8,636 | $30.03 | $259K | 14,478 |
| 2025-02-05 | KOCH KEVIN President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,636 | 42,545 | ||
| 2025-02-05 | Derakhshan Behrad Chief Business Officer | Option exercise | +10,000 | $1.93 | $19K | 26,837 |
| 2025-02-05 | Derakhshan Behrad Chief Business Officer | Sale | −10,000 | $30.03 | $300K | 16,837 |
| 2025-02-05 | Derakhshan Behrad Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −10,000 | 92,929 | ||
| 2025-01-28 | Donovan Joanne M. CMO | Option exercise 10b5-1 | +25,000 | $7.08 | $177K | 41,358 |
| 2025-01-28 | Donovan Joanne M. CMO | Sale 10b5-1 | −25,000 | $27.63 | $691K | 16,358 |
Page 10 of 26 · 509 trades